Louis Griffel

Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients

Ira M. Jacobson, Robert S. Brown, Bradley Freilich et al. · Hepatology · 2007 · 306 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy

Thierry Poynard, Massimo Colombo, Jordi Bruix et al. · Gastroenterology · 2009 · 235 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +15

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up

Maria Domenica Cappellini, Mohamed Béjaoui, Leyla Ağaoğlu et al. · Blood · 2011 · 220 citations · Full text

Medicine, Hematology, Pharmacology +14

A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE -Related Hereditary Hemochromatosis

Pradyumna D. Phatak, Pierre Brissot, Mark Wurster et al. · Hepatology · 2010 · 129 citations · Full text

Medicine, Hematology, Pharmacology +17

Maintenance Therapy With Peginterferon Alfa-2b Does Not Prevent Hepatocellular Carcinoma in Cirrhotic Patients With Chronic Hepatitis C

Jordi Bruix, Thierry Poynard, Massimo Colombo et al. · Gastroenterology · 2011 · 106 citations · Full text

Pharmacy, Pharmacotherapy, Hepatic Pharmacotherapy +16